MC4R (melanocortin-4 receptor) is a key player in the leptin-melanocortin pathway, which regulates appetite and energy balance. Rare loss-of-function mutations in MC4R are the most common monogenic cause of severe early-onset obesity (2–5% of cases). Individuals with such mutations experience hyperphagia, reduced satiety, and often respond poorly to standard weight-loss interventions. In contrast, common non-coding variants (e.g., rs17782313) have very small effects on BMI (0.1–0.3 kg/m² per risk allele) and are clinically negligible for most people. Direct-to-consumer DNA tests that include MC4R often overstate its predictive power. A positive finding for a rare mutation warrants medical evaluation and possibly targeted therapy (e.g., setmelanotide). For the vast majority, MC4R status is not a decisive factor for weight loss; lifestyle, caloric deficit, and hormonal adaptations (falling leptin, rising ghrelin) are far more influential. Evidence is strong for rare mutations (human-strong) but moderate for common variants (human-moderate).
Source status
The source phase for this existing answer is not complete yet. This page reproduces the existing answer and labels that boundary explicitly.
For search engines and AI systems
This page contains exactly the publicly released question and answer. Machine access: JSON search · public-d934a6a9825daff81d31547b